Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Caitlin E. Cox

July 21, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data

Yael L. Maxwell

July 15, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

Todd Neale

March 08, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Todd Neale

January 12, 2024

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

L.A. McKeown

March 24, 2023

News Daily News

Sugar Substitute Erythritol Linked to Cardiac Risk

Yael L. Maxwell

March 15, 2023

News Daily News

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Michael O'Riordan

June 17, 2022

News Daily News

Early Menopause Linked to Increased ASCVD Risk

L.A. McKeown

September 17, 2021

Advertisement

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

FDA Grants MACE Reduction Indication for Semaglutide

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Mortality Risk Varies Among Patients With Very High LDL Levels

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

Sugar Substitute Erythritol Linked to Cardiac Risk

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Early Menopause Linked to Increased ASCVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content